Calumet Specialty Products Partners, L.P (NASDAQ:CLMT) shares saw an uptick in trading volume on Thursday . 447,338 shares changed hands during trading, a decline of 8% from the previous session’s volume of 486,078 shares.The stock last traded at $5.05 and had previously closed at $4.98.

Several research firms have recently weighed in on CLMT. Credit Suisse Group AG raised their price objective on shares of Calumet Specialty Products Partners, L.P from $6.00 to $11.00 and gave the stock an “underperform” rating in a report on Monday, April 25th. DA Davidson lowered shares of Calumet Specialty Products Partners, L.P from a “buy” rating to an “underperform” rating and set a $5.00 price objective for the company. in a report on Tuesday, April 19th. Cowen and Company dropped their price objective on shares of Calumet Specialty Products Partners, L.P from $23.00 to $10.00 and set a “market perform” rating for the company in a report on Monday, April 18th. Howard Weil lowered shares of Calumet Specialty Products Partners, L.P to an “underperform” rating in a report on Tuesday, April 19th. Finally, Wells Fargo & Co. lowered shares of Calumet Specialty Products Partners, L.P from an “outperform” rating to a “market perform” rating in a report on Monday, April 18th. Five analysts have rated the stock with a sell rating and eleven have given a hold rating to the stock. Calumet Specialty Products Partners, L.P has an average rating of “Hold” and an average price target of $10.71.

The firm’s market cap is $368.91 million. The stock’s 50-day moving average price is $4.81 and its 200 day moving average price is $9.07.

Calumet Specialty Products Partners, L.P (NASDAQ:CLMT) last posted its quarterly earnings data on Thursday, May 5th. The company reported ($0.87) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.83) by $0.04. Equities analysts predict that Calumet Specialty Products Partners, L.P will post ($1.73) EPS for the current year.

In other news, EVP A Anderson William bought 10,000 shares of the company’s stock in a transaction dated Monday, May 9th. The stock was bought at an average cost of $4.07 per share, for a total transaction of $40,700.00. Following the transaction, the executive vice president now owns 25,392 shares of the company’s stock, valued at $103,345.44. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Stephen P. Mawer bought 11,000 shares of the company’s stock in a transaction dated Wednesday, May 18th. The stock was purchased at an average price of $3.68 per share, with a total value of $40,480.00. Following the completion of the transaction, the director now directly owns 5,025 shares in the company, valued at approximately $18,492. The disclosure for this purchase can be found here.

Several institutional investors have recently modified their holdings of CLMT. Marshall Wace LLP purchased a new position in shares of Calumet Specialty Products Partners, L.P during the fourth quarter valued at approximately $4,173,000. Morgan Stanley boosted its position in shares of Calumet Specialty Products Partners, L.P by 51.9% in the fourth quarter. Morgan Stanley now owns 860,510 shares of the company’s stock valued at $17,133,000 after buying an additional 293,839 shares during the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its position in shares of Calumet Specialty Products Partners, L.P by 212.4% in the fourth quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 120,664 shares of the company’s stock valued at $2,402,000 after buying an additional 82,035 shares during the last quarter.

Calumet Specialty Products Partners, L.P. (Calumet) is a producer of specialty hydrocarbon products in North America. The Company’s segments include specialty products, fuel products and oilfield services. In its specialty products segment, it processes crude oil and other feedstocks into a range of customized lubricating oils, white mineral oils, solvents, petrolatums and waxes.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.